Paediatric infliximab therapy: patients' and parents' perspectives on treatment options

• DOI: 10.1185/146300908x292097
• Publication Date: 2008-06-23T21:22:31Z
• Authors: Ankie C M Hazen; Felicity J Smith; Kevin M G Taylor; Christine Rawcliffe; Lucy Medcalf; Simon Keady
• Keywords: 03 medical and health sciences; 0305 other medical science; 3. Good health

Aim: To assess patients' and parents' perspectives on the impact of infliximab treatment daily life acceptability feasibility (infliximab or adalimumab) home treatment, in light perceived value hospital services. Methods: A descriptive qualitative study was conducted at University College Hospital London. Data were collected via 25 semi-structured interviews with patients (aged 14-19) from both gastroenterology rheumatology specialties, prescribed infliximab, their parents. Results: The majority participants preferred to continue current hospital, rather than be treated local home. main reasons specialised care continuity staff, resistance method adalimumab administration expected problems compliance. services highly valued considered have either no family school life, improved it. Conclusion: Infliximab is an effective therapy for inflammatory bowel diseases conditions young people, bringing negative on, improvement life. In association positive appraisal confidence clinical team, parents do not express a preference despite health policy aimed towards closer to, at,